Tokyo Tape
Sign in
← Torii Pharmaceutical

Annual report

4551.TEDINET S100QGWM
Period2022-01-01 → 2022-12-31
Filed2023-03-28
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 89
MetricValuePeriodScopeSource row
Revenue¥48.9bn2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥47.0bn2021-01-01 → 2021-12-31StandaloneNet sales
Revenue¥41.7bn2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥43.0bn2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Revenue¥62.6bn2018-01-01 → 2018-12-31dStandaloneNet sales (5-year summary)
Operating income¥5.5bn2022-01-01 → 2022-12-31StandaloneOperating income
Operating income¥4.7bn2021-01-01 → 2021-12-31StandaloneOperating income
Ordinary income¥5.5bn2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income¥4.8bn2021-01-01 → 2021-12-31StandaloneOrdinary income
Ordinary income¥5.0bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥1.7bn2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥5.1bn2018-01-01 → 2018-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥5.7bn2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Profit before tax¥4.8bn2021-01-01 → 2021-12-31StandaloneIncome before income taxes
Net income¥3.9bn2022-01-01 → 2022-12-31StandaloneProfit loss
Net income¥3.4bn2021-01-01 → 2021-12-31StandaloneProfit loss
Net income¥3.5bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income¥27.4bn2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Net income¥1.2bn2018-01-01 → 2018-12-31dStandaloneNet income loss (5-year summary)
Total assets¥133.7bnat 2022-12-31StandaloneAssets
Total assets¥130.8bnat 2021-12-31StandaloneAssets
Total assets¥126.0bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥139.9bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total assets¥103.3bnat 2018-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥14.5bnat 2022-12-31StandaloneLiabilities
Total liabilities¥13.8bnat 2021-12-31StandaloneLiabilities
Net assets / equity¥119.2bnat 2022-12-31StandaloneNet assets
Net assets / equity¥117.0bnat 2021-12-31StandaloneNet assets
Net assets / equity¥115.1bnat 2020-12-31dStandaloneNet assets
Net assets / equity¥113.1bnat 2019-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥87.1bnat 2018-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥9.2bnat 2022-12-31StandaloneCash and deposits
Cash and deposits¥4.0bnat 2021-12-31StandaloneCash and deposits
Cash & equivalents¥45.4bnat 2022-12-31StandaloneCash and cash equivalents
Cash & equivalents¥58.4bnat 2021-12-31StandaloneCash and cash equivalents
Cash & equivalents¥61.6bnat 2020-12-31dStandaloneCash and cash equivalents
Cash & equivalents¥58.8bnat 2019-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥15.7bnat 2018-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥2.4bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥156m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥3.4bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥42.5bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥8.3bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥13.7bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥1.5bn2021-01-01 → 2021-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow¥7.6bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥2.1bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥27.1bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥1.7bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥1.5bn2021-01-01 → 2021-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥1.4bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.4bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.4bn2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥140.392022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥120.132021-01-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥124.472020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥974.982019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥41.512018-01-01 → 2018-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥124.462020-01-01 → 2020-12-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥1002022-01-01 → 2022-12-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥482021-01-01 → 2021-12-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥482020-01-01 → 2020-12-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥482019-01-01 → 2019-12-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥482018-01-01 → 2018-12-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥4,243.08at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥4,165.38at 2021-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥4,097.55at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥4,029.3at 2019-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥3,103.28at 2018-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio89.2%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio89.5%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio91.3%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio80.8%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio84.3%at 2018-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE3.3%2022-01-01 → 2022-12-31StandaloneRate of return on equity (5-year summary)
ROE2.9%2021-01-01 → 2021-12-31StandaloneRate of return on equity (5-year summary)
ROE3.1%2020-01-01 → 2020-12-31dStandaloneRate of return on equity (5-year summary)
ROE27.3%2019-01-01 → 2019-12-31dStandaloneRate of return on equity (5-year summary)
ROE1.3%2018-01-01 → 2018-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued28,800,000at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2021-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2018-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees563at 2022-12-31StandaloneNumber of employees
Employees560at 2021-12-31StandaloneNumber of employees
Employees568at 2020-12-31dStandaloneNumber of employees
Employees660at 2019-12-31dStandaloneNumber of employees
Employees1,049at 2018-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 1
SegmentItemPeriodValue
Pharmaceutical Businessreportable segmentemployeesat 2022-12-31563 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 987
ItemContextValueUnit
Dividends from surplusCurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember-1348000000JPY
Dividends from surplusCurrentYearDuration_NonConsolidatedMember-1348000000JPY
Profit lossCurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember3944000000JPY
Profit lossCurrentYearDuration_NonConsolidatedMember3944000000JPY
Purchase of treasury stockCurrentYearDuration_NonConsolidatedMember_TreasuryStockMember-0JPY
Purchase of treasury stockCurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember-0JPY
Purchase of treasury stockCurrentYearDuration_NonConsolidatedMember-0JPY
Disposal of treasury stockCurrentYearDuration_NonConsolidatedMember_TreasuryStockMember12000000JPY
Disposal of treasury stockCurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember20000000JPY
Disposal of treasury stockCurrentYearDuration_NonConsolidatedMember20000000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember-406000000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember-406000000JPY
Net changes of items other than shareholders equityCurrentYearDuration_NonConsolidatedMember-406000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_TreasuryStockMember11000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ShareholdersEquityMember2615000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember-406000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember-406000000JPY
Total changes of items during the periodCurrentYearDuration_NonConsolidatedMember2209000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_TreasuryStockMember-1381000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ShareholdersEquityMember119107000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ValuationDifferenceOnAvailableForSaleSecuritiesMember117000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember_ValuationAndTranslationAdjustmentsMember117000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember119224000000JPY
Income before income taxesPrior1YearDuration_NonConsolidatedMember4767000000JPY
Income before income taxesCurrentYearDuration_NonConsolidatedMember5722000000JPY
Depreciation and amortization ope cfPrior1YearDuration_NonConsolidatedMember413000000JPY
Depreciation and amortization ope cfCurrentYearDuration_NonConsolidatedMember454000000JPY
Interest and dividends income ope cfPrior1YearDuration_NonConsolidatedMember-281000000JPY
Interest and dividends income ope cfCurrentYearDuration_NonConsolidatedMember-313000000JPY
Interest expenses ope cfPrior1YearDuration_NonConsolidatedMember0JPY
Interest expenses ope cfCurrentYearDuration_NonConsolidatedMember0JPY
Loss gain on sales and retirement of noncurrent assets ope cfPrior1YearDuration_NonConsolidatedMember37000000JPY
Loss gain on sales and retirement of noncurrent assets ope cfCurrentYearDuration_NonConsolidatedMember1000000JPY
Restructuring expenses ope cfPrior1YearDuration_NonConsolidatedMember12000000JPY
Restructuring expenses ope cfCurrentYearDuration_NonConsolidatedMember－JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1YearDuration_NonConsolidatedMember-3052000000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYearDuration_NonConsolidatedMember-854000000JPY
Decrease increase in inventories ope cfPrior1YearDuration_NonConsolidatedMember-1610000000JPY
Decrease increase in inventories ope cfCurrentYearDuration_NonConsolidatedMember-206000000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1YearDuration_NonConsolidatedMember649000000JPY
Increase decrease in notes and accounts payable trade ope cfCurrentYearDuration_NonConsolidatedMember791000000JPY
Increase decrease in accounts payable other ope cfPrior1YearDuration_NonConsolidatedMember189000000JPY
Increase decrease in accounts payable other ope cfCurrentYearDuration_NonConsolidatedMember-523000000JPY
Increase decrease in accrued consumption taxes ope cfPrior1YearDuration_NonConsolidatedMember330000000JPY
Increase decrease in accrued consumption taxes ope cfCurrentYearDuration_NonConsolidatedMember-4000000JPY
Decrease increase in long term prepaid expenses ope cfPrior1YearDuration_NonConsolidatedMember-2155000000JPY
Decrease increase in long term prepaid expenses ope cfCurrentYearDuration_NonConsolidatedMember-361000000JPY
Other net ope cfPrior1YearDuration_NonConsolidatedMember205000000JPY
Other net ope cfCurrentYearDuration_NonConsolidatedMember-613000000JPY
Subtotal ope cfPrior1YearDuration_NonConsolidatedMember-494000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2021-12-31pass
balance sheet identitynon_consolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-12-31pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · operating cash flownon_consolidated 2021-01-01/2021-12-31pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2021-01-01/2021-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · total assetsnon_consolidated 2021-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass